J. Goldman & Co’s iShares US Medical Devices ETF IHI Stock Holding History

J. Goldman & Co’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.15M	Hold	83,942	–	–	0.11%	231
2026 Q1	$4.48M	Hold	83,942	–	–	0.13%	197
2025 Q4	$5.22M	Buy	83,942 +10,604	+14%	+$655K	0.14%	189
2025 Q3	$4.41M	Hold	73,338	–	–	0.11%	213
2025 Q2	$4.59M	Hold	73,338	–	–	0.11%	204
2025 Q1	$4.41M	Hold	73,338	–	–	0.11%	224
2024 Q4	$4.28M	Sell	73,338 -6,285	-8%	-$374K	0.11%	205
2024 Q3	$4.72M	Hold	79,623	–	–	0.13%	167
2024 Q2	$4.46M	Buy	+79,623	New	+$4.46M	0.13%	183
2021 Q3	–	Sell	-19,884	Closed	-$1.2M	–	396
2021 Q2	$1.2M	Buy	19,884 +1,632	+9%	+$94.4K	0.05%	270
2021 Q1	$1M	Sell	18,252 -5,418	-23%	-$300K	0.03%	303
2020 Q4	$1.29M	Buy	23,670 +5,850	+33%	+$306K	0.07%	222
2020 Q3	$890K	Sell	17,820 -6,516	-27%	-$316K	0.06%	219
2020 Q2	$1.07M	Buy	24,336 +12,558	+107%	+$537K	0.07%	190
2020 Q1	$442K	Sell	11,778 -21,750	-65%	-$916K	0.05%	179
2019 Q4	$1.48M	Buy	+33,528	New	+$1.41M	0.11%	165

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

J. Goldman & Co's IHI Position: Q2 2026 in Review

J. Goldman & Co held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 83,942 shares worth $4.15M. The position accounts for 0.11% of the portfolio, ranked #231.

J. Goldman & Co first reported a position in IHI in Q4 2019 and has held it in 16 quarters since. The position peaked at $5.22M in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

J. Goldman & Co held 83,942 shares of iShares US Medical Devices ETF worth $4.15M as of Q2 2026.
J. Goldman & Co left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up 0.11% of J. Goldman & Co's portfolio in Q2 2026, its #231 holding.
J. Goldman & Co first reported a position in iShares US Medical Devices ETF in Q4 2019 and has held it in 16 quarters since.
J. Goldman & Co's iShares US Medical Devices ETF position peaked at $5.22M in Q4 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.